First Quadrant’s DexCom DXCM Stock Holding History

First Quadrant’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-332	Closed	-$30K	–	542
2021 Q1	$30K	Hold	332	–	–	﹤0.01%	491
2020 Q4	$31K	Sell	332 -1,900	-85%	-$170K	﹤0.01%	492
2020 Q3	$230K	Sell	2,232 -732	-25%	-$76.5K	0.03%	326
2020 Q2	$300K	Sell	2,964 -996	-25%	-$89.1K	0.04%	347
2020 Q1	$267K	Buy	3,960 +1,560	+65%	+$97.1K	0.04%	360
2019 Q4	$131K	Hold	2,400	–	–	0.01%	454
2019 Q3	$90K	Hold	2,400	–	–	0.01%	493
2019 Q2	$90K	Hold	2,400	–	–	0.01%	594
2019 Q1	$71K	Sell	2,400 -76	-3%	-$2.67K	0.01%	616
2018 Q4	$74K	Buy	2,476 +76	+3%	+$2.41K	0.01%	681
2018 Q3	$86K	Hold	2,400	–	–	﹤0.01%	730
2018 Q2	$57K	Hold	2,400	–	–	﹤0.01%	687
2018 Q1	$44K	Hold	2,400	–	–	﹤0.01%	749
2017 Q4	$34K	Hold	2,400	–	–	﹤0.01%	865
2017 Q3	$29K	Hold	2,400	–	–	﹤0.01%	872
2017 Q2	$44K	Hold	2,400	–	–	﹤0.01%	833
2017 Q1	$51K	Hold	2,400	–	–	﹤0.01%	751
2016 Q4	$36K	Hold	2,400	–	–	﹤0.01%	785
2016 Q3	$53K	Hold	2,400	–	–	﹤0.01%	780
2016 Q2	$48K	Hold	2,400	–	–	﹤0.01%	714
2016 Q1	$41K	Hold	2,400	–	–	﹤0.01%	700
2015 Q4	$49K	Buy	+2,400	New	+$49.9K	﹤0.01%	663

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

First Quadrant's DXCM Position: Q2 2021 in Review

First Quadrant sold out of DexCom (DXCM) in Q2 2021, closing a stake of 332 shares — an estimated $30K sold.

First Quadrant first reported a position in DXCM in Q4 2015 and held it in 22 quarters. The position peaked at $300K in Q2 2020. 728 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

First Quadrant reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
First Quadrant sold 332 DexCom shares in Q2 2021, an estimated $30K.
First Quadrant first reported a position in DexCom in Q4 2015 and held it in 22 quarters.
First Quadrant's DexCom position peaked at $300K in Q2 2020.
728 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on First Quadrant's 13F filing for Q2 2021, filed 23 Jul 2021.